Before | Immediately After | One Week After | Two Weeks After | |||||
---|---|---|---|---|---|---|---|---|
Variable | P | P | P | P | ||||
Overalla | 1.95 ± 0.99 | - | 1.82 ± 0.93 | 0.030* | 0.40 ± 0.16 | < 0.001* | 1.34 ± 0.44 | < 0.001* |
Age (years) | ||||||||
≤30 | 1.95 ± 0.98 | 1.71 ± 0.96 | 0.38 ± 0.14 | 1.30 ± 0.37 | ||||
31-40 | 1.68 ± 0.99 | 1.58 ± 0.77 | 0.39 ± 0.18 | 1.31 ± 0.48 | ||||
> 40 | 2.18 ± 0.99 | 0.324 | 2.16 ± 0.95 | 0.123 | 0.44 ± 0.16 | 0.504 | 1.43 ± 0.51 | 0.597 |
Gender | ||||||||
Male | 2.37 ± 1.14 | 2.00 ± 0.79 | 0.45 ± 0.17 | 1.38 ± 0.42 | ||||
Female | 1.83 ± 0.93 | 0.075 | 1.77 ± 0.96 | 0.401 | 0.39 ± 0.15 | 0.193 | 1.33 ± 0.45 | 0.700 |
Education level | ||||||||
Below college | 2.07 ± 1.18 | 2.01 ± 1.12 | 0.41 ± 0.17 | 1.37 ± .48 | ||||
College and above | 1.83 ± 0.76 | 0.340 | 1.62 ± 0.64 | 0.100 | 0.40 ± 0.15 | 0.843 | 1.31 ± 0.41 | 0.569 |
Body weight change (kg) | ||||||||
< 2 | 1.69 ± 0.69 | 1.61 ± 0.73 | 0.37 ± 0.14 | 1.28 ± 0.38 | ||||
≥2 | 2.84 ± 1.36 | < 0.001* | 2.54 ± 01.19 | 0.001* | 0.50 ± 0.18 | 0.009 | 1.57 ± 0.59 | 0.031* |
Drug dosage (mg) | ||||||||
≤500 | 1.75 ± 0.79 | 1.65 ± 0.74 | 0.38 ± 0.15 | 1.32 ± 0.41 | ||||
> 501 | 2.09 ± 1.10 | 0.175 | 1.94 ± 1.03 | 0.227 | 0.41 ± 0.17 | 0.455 | 1.36 ± 0.47 | 0.737 |
Frequency of treatment | ||||||||
1 | 1.72 ± 0.63 | 1.57 ± 0.59 | 0.39 ± 0.14 | 1.31 ± 0.39 | ||||
≥2 | 2.15 ± 1.19 | 0.088 | 2.03 ± 1.11 | 0.048* | 0.41 ± 0.17 | 0.735 | 1.36 ± 0.49 | 0.657 |
Diagnosis | ||||||||
SLE group | 2.14 ± 1.16 | 2.03 ± 1.09 | 0.41 ± 0.16 | 1.29 ± 0.37 | ||||
Non-SLE group | 1.87 ± 0.91 | 0.310 | 1.72 ± 0.84 | 0.230 | 0.40 ± 0.16 | 0.727 | 1.36 ± 0.48 | 0.547 |
Hospital stay (days) | ||||||||
≤5 | 1.55 ± 0.92 | 1.55 ± 0.99 | 0.34 ± 0.13 | 1.23 ± 0.45 | ||||
6-10 | 2.09 ± 0.91 | 1.83 ± 0.68 | 0.38 ± 0.13 | 1.24 ± 0.27 | ||||
≥11 | 2.19 ± 1.05 | 0.080 | 2.04 ± 1.03 | 0.230 | 0.47 ± 0.18 | 0.019* | 1.52 ± 0.51 | 0.043* |